Alhibshi et al
Wu, G., Fang, YZ, Yang, S., Lupton, JR, & Turner, ND (2004)
Cagrilintide No - amyloid fibril risk Retatrutide No - standard peptide handling State Light protection Cagrilintide Yes Retatrutide Yes State Oral viable Cagrilintide No Retatrutide No Both compounds share similar refrigerator windows
Since AAVs have been found to integrate within DSBs with high frequency [152], the coupling of CRISPR-Cas9 with AAVs as the delivery vector must be carefully evaluated before clinical translation [58, 153]
In this way, understanding high-functioning autism becomes less about labels and more about creating environments where autistic individuals can thrive, contribute, and live fulfilling lives
January 2017